Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-02-13-Speech-2-176"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20010213.9.2-176"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"Question No 45 by Alexandros Alavanos ():
Intense concern has been caused in Europe by revelations concerning the development of leukaemia among members of the international forces who served in Bosnia and Kosovo, which has been attributed to the use of depleted uranium bombs. In reply to one of my previous questions ()the Commission indicated that (a) the report by the Regional Environmental Centre for Central and Eastern Europe had been forwarded to the Environment Ministers of the Member States in June 1999 and (b) detailed analysis of the situation regarding funding for clean-up measures had not yet been carried out.
In view of the fact that no answers to this particular issue were forthcoming at the January part-session and that the Commissioner referred to a meeting of an independent group of experts, does the Commission not consider highly alarming the implications of the report for the health of civilians and servicemen in these areas? Who will assume responsibility for medical examination programmes for the populations of the areas affected by depleted uranium bombs? What are the conclusions of the meeting of independent experts to which the Commissioner referred and what additional measures are to be taken?"@en1
|
lpv:unclassifiedMetadata |
"Subject: Consequences of the use of depleted uranium bombs in Kosovo"1
|
Named graphs describing this resource:
The resource appears as object in 2 triples